Cargando…
P1426: WU-NK-101, AN ALLOGENEIC MEMORY NK CELL, FOR THE TREATMENT OF RELAPSE OR REFRACTORY (R/R) ACUTE MYELOID LEUKEMIA (AML)
Autores principales: | Muth, J. J., Mathyer, M. E., Cruz, B., DuFour, C., Leedom, T., Hamil, A. S., Pouyanfard, S., Berrien-Elliot, M., Luukkonen, L., Tran, M., Tumala, B., Pomper, N., Arthur, L., Foster, M., Gorrochategui, J., Comune Pennacchi, P., Primo, D., Ballesteros, J., Tolstikov, V., Kiebish, M. A., Shah, P., Vadakekolathu, J., Rutella, S., Fehniger, T. A., Sullivan, R., Kabakibi, A., Cooper, M. L., Davidson-Moncada, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429392/ http://dx.doi.org/10.1097/01.HS9.0000848560.56093.16 |
Ejemplares similares
-
S129: ADOPTIVELY INFUSED MEMORY-LIKE (ML) NATURAL KILLER (NK) CELLS ELICIT ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
por: Rutella, Sergio, et al.
Publicado: (2023) -
Flow cytometry-based ex vivo murine NK cell cytotoxicity assay
por: Wong, Pamela, et al.
Publicado: (2021) -
CD56 regulates human NK cell cytotoxicity through Pyk2
por: Gunesch, Justin T, et al.
Publicado: (2020) -
Memory-like Differentiation Enhances NK Cell Responses to Melanoma
por: Marin, Nancy D., et al.
Publicado: (2021) -
Good manufacturing practice production of CD34(+) progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia
por: de Jonge, P. K. J. D., et al.
Publicado: (2023)